Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
- 21 December 2004
- journal article
- review article
- Published by Elsevier
- Vol. 105 (3) , 267-310
- https://doi.org/10.1016/j.pharmthera.2004.10.007
Abstract
No abstract availableKeywords
This publication has 390 references indexed in Scilit:
- Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in ratsSynapse, 2003
- Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: Evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritisArthritis & Rheumatism, 2000
- Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neuronsAmino Acids, 1998
- Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic studySynapse, 1997
- CARDIOPROTECTIVE EFFECTS OF ADENOSINE A1AND A2ARECEPTOR AGONISTS IN THE ISOLATED RAT HEARTPharmacological Research, 1997
- Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaineSynapse, 1996
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neuronsJournal of Comparative Neurology, 1995
- CGS 15943, An adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbilLife Sciences, 1994
- Evidence for functionally important adenosine A2a receptors in the rat hippocampusBrain Research, 1994